KPT — KP Tissue Cashflow Statement
0.000.00%
Last trade - 00:00- CA$80.25m
- CA$80.25m
- 26
- 72
- 44
- 45
Annual cashflow statement for KP Tissue, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.95 | 1.24 | -10.2 | -4.94 | 2.43 |
| Deferred Taxes | |||||
| Non-Cash Items | 1.95 | -1.24 | 10.2 | 4.94 | -2.49 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0 | 0 | 0 | 0 | 0 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0 | 0 | 0 | 0 | 0 |
| Other Investing Cash Flow Items | 5.59 | 5.56 | 6.62 | 6.98 | 6.97 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 5.59 | 5.56 | 6.62 | 6.98 | 6.97 |
| Total Cash Dividends Paid | |||||
| Cash from Financing Activities | -5.59 | -5.56 | -6.62 | -6.98 | -6.97 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0 | 0 | 0 | 0 |